PAK4 orchestrates dual transcriptional and post-translational repression of E-cadherin to promote epithelial-to-mesenchymal transition and invasiveness in pancreatic cancer
Kui-Jin Kim, Cheng Hyun Lee, Milang Nam, Hee Young Na, Ji Hea Sung, Bo-Ram Park, Sung-Hyun Hwang, Woochan Park, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji Yun Lee, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Zev A. Wainberg, Jin Won Kim Cancer Gene Therapy
· Springer Nature
· 2026-10-31
· DOI: 10.1038/s41417-026-01091-y
Аннотация
Cancer Gene Therapy, Published online: 31 October 2026; doi:10.1038/s41417-026-01091-y PAK4 orchestrates dual transcriptional and post-translational repression of E-cadherin to promote epithelial-to-mesenchymal transition and invasiveness in pancreatic cancer
Kui-Jin Kim, Cheng Hyun Lee, Milang Nam, Hee Young Na, Ji Hea Sung, Bo-Ram Park et al. PAK4 orchestrates dual transcriptional and post-translational repression of E-cadherin to promote epithelial-to-mesenchymal transition and invasiveness in pancreatic cancer. // Cancer Gene Therapy. – 2026. – DOI: 10.1038/s41417-026-01091-y. – URL: https://www.nature.com/articles/s41417-026-01091-y
Kui-Jin Kim, Cheng Hyun Lee, Milang Nam, Hee Young Na, Ji Hea Sung, Bo-Ram Park, Sung-Hyun Hwang, Woochan Park, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji Yun Lee, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Zev A. Wainberg, & Jin Won Kim (2026). PAK4 orchestrates dual transcriptional and post-translational repression of E-cadherin to promote epithelial-to-mesenchymal transition and invasiveness in pancreatic cancer. Cancer Gene Therapy. https://doi.org/10.1038/s41417-026-01091-y
Kui-Jin Kim, et al. “PAK4 orchestrates dual transcriptional and post-translational repression of E-cadherin to promote epithelial-to-mesenchymal transition and invasiveness in pancreatic cancer.” Cancer Gene Therapy, 2026. doi:10.1038/s41417-026-01091-y.
@article{Kim2026,
title = {PAK4 orchestrates dual transcriptional and post-translational repression of E-cadherin to promote epithelial-to-mesenchymal transition and invasiveness in pancreatic cancer},
author = {Kim, Kui-Jin and Lee, Cheng Hyun and Nam, Milang and Na, Hee Young and Sung, Ji Hea and Park, Bo-Ram and Hwang, Sung-Hyun and Park, Woochan and Seo, Jeongmin and Kang, Minsu and Jung, Eun Hee and Kim, Sang-A and Suh, Koung Jin and Lee, Ji Yun and Kim, Ji-Won and Kim, Se Hyun and Lee, Jeong-Ok and Kim, Yu Jung and Lee, Keun-Wook and Kim, Jee Hyun and Bang, Soo-Mee and Wainberg, Zev A. and Kim, Jin Won},
journal = {Cancer Gene Therapy},
year = {2026},
doi = {10.1038/s41417-026-01091-y},
url = {https://www.nature.com/articles/s41417-026-01091-y}
}
Gene Therapy, Published online: 13 November 2026; doi:10.1038/s41434-026-00658-6 Clinical landscape of gene therapy for rare diseases: a registry-based analysis of clinical trials and FDA-approved products
Human Genome Variation, Published online: 12 November 2026; doi:10.1038/s41439-026-00361-3 Arthrogryposis involves multiple joint contractures present at birth, affecting both upper and lower extremities. This study investigates the...
Gene Therapy, Published online: 10 November 2026; doi:10.1038/s41434-026-00657-7 Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
Gene Therapy, Published online: 04 November 2026; doi:10.1038/s41434-026-00649-7 High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Gene Therapy, Published online: 03 November 2026; doi:10.1038/s41434-026-00656-8 Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials